Efficacy and drug survival after transitioning to IL-17 inhibitors in patients with psoriasis who did not respond to IL-23 inhibitors: analysis from the BIOREP registry.

Bimzelx (bimekizumab-bkzx) - UCB

http://www.ncbi.nlm.nih.gov/pubmed/42427208

Alena Machovcova; Filip Rob; Marie Jandová; Martin Tichy; Martina Kojanova; Petra Cetkovska; Spyridon Gkalpakiotis; Yveta Vantuchová

Jul 11, 2026